GI Oncology
From the Journals
Impact of eliminating cost-sharing on follow-up colonoscopy mixed
Eliminating cost-sharing of follow up colonoscopy after a positive noninvasive test led to a boost in follow-up colonoscopies in one state, but...
Perspectives
Will ESD replace EMR for large colorectal polyps?
How can we justify higher recurrence rates with EMR when ESD is available? Will reimbursement continue to favor EMR?
Conference Coverage
At-home colorectal cancer testing and follow-up vary by ethnicity
Researchers examined disparities by patient ethnicity in colorectal cancer test ordering by physicians and follow-up colonoscopy rates.
Conference Coverage
Artificial intelligence colonoscopy system shows promise
A new artificial intelligence colonoscopy system improved the accuracy of experienced endoscopists in the United States.
From the AGA Journals
AGA issues position statements on reducing CRC burden
The American Gastroenterological Association has published eight position statements aimed at reducing the burden of colorectal cancer (CRC).
...From the AGA Journals
AI-based CADe outperforms high-definition white light in colonoscopy
Computer-assisted detection has the potential to decrease interprovider variability by reducing AMR, even in experienced providers.
From the Journals
Esophageal cancer screening isn’t for everyone: Study
A new cost-effectiveness analysis study suggests that the optimal endoscopic screening strategy for esophageal adenocarcinoma varies by race and...
Short Clinical Reviews
Endoscopic management of duodenal and ampullary adenomas
EMR in the duodenum is tricky because of its thin muscle layer, increased motility, and significant vascular supply.
Conference Coverage
Alarming increase in esophageal cancer in middle-aged adults
The prevalence of esophageal cancer and Barrett’s esophagus has increased substantially among middle-age adults over the past 5 years, warn the...
Conference Coverage
CRC screening: Blood test accuracy compared to colonoscopy
At 90% specificity, the blood assay (Guardant Health) was 100% sensitive for detecting CRC.